Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

Lilly's Lechleiter isn't budging from stand-alone $5B R&D strategy--yet
Fierce Biotech
Mon, 10/21/13 - 11:55 am
Tags:
John Lechleiter, R&D, Eli Lilly
Can Eli Lilly Earnings Keep Up With Merck and Pfizer?
Motley Fool
Mon, 10/21/13 - 11:52 am
Tags:
Eli Lilly, earnings, Merck, Pfizer
Universities Stepping Up Efforts To Discover Drugs
Forbes
Mon, 10/21/13 - 09:32 am
Tags:
R&D, Eli Lilly, Academic Drug Discovery Consortium, ADDC
Pfizer: The Menopause Opportunity
Seeking Alpha
Fri, 10/18/13 - 06:19 pm
Tags:
Pfizer, Duavee, menopause, Ligand Pharmaceuticals, Eli Lilly, Hisamitsu, hot flashes
Is Eli Lilly about to start cutting its blockbuster R&D budget?
Fierce Biotech
Thu, 10/17/13 - 10:49 am
Tags:
R&D, Eli Lilly
Analysts' Actions: AIZ GLW JNJ LLY MRK
Yahoo/TheStreet.com
Fri, 10/11/13 - 09:35 am
Tags:
JNJ, Eli Lilly, Merck, Pharmacyclics
How the Game Changed Against Big Pharma - Creating New Opportunities
Forbes
Wed, 10/9/13 - 03:58 pm
Tags:
Merck, Pfizer, Eli Lilly, Big Pharma, Sanofi, Roche, GSK, Abbott Laboratories, Melinta Therapeutics, antibiotics, delafloxacin
Former Lilly Employees Charged With Stealing R&D Secrets
Pharmalot
Wed, 10/9/13 - 09:37 am
Tags:
China, R&D, Eli Lilly
Tonix Developing Treatment Overlap For Fibromyalgia And PTSD
Seeking Alpha
Tue, 10/8/13 - 03:53 pm
Tags:
Tonix, PTSD, fibromyalgia, Forest Labs, Eli Lilly, Pfizer
Will This Company Face the Same Restructuring as Merck?
Motley Fool
Mon, 10/7/13 - 08:45 am
Tags:
Merck, layoffs, Eli Lilly, restructuring
New class of psoriasis drugs being developed
Bloomberg
Fri, 10/4/13 - 10:14 am
Tags:
psoriasis, Novartis, AstraZeneca, Amgen, Eli Lilly, Enbrel, secukinumab, brodalumab, IL-17 blockers
Lilly Challenged to Hit Sales Goal Announces Buyback
Bloomberg
Thu, 10/3/13 - 09:09 am
Tags:
Eli Lilly
Lilly mulls options as Medicare shuns Alzheimer's diagnostic
Yahoo/AP
Mon, 09/30/13 - 04:48 pm
Tags:
Eli Lilly, Medicare, Alzheimer's disease, diagnostics, Amyvid
Which Alzheimer's Fighter Will Benefit From a Boost in Federal Funding?
Motley Fool
Mon, 09/30/13 - 04:29 pm
Tags:
Alzheimer's disease, LY2886721, Eli Lilly, MK-8931, Merck, bapineuzumab, JNJ, solanezumab, Gammagard, Baxter International
Lilly Disappointed in Medicare Decision to Deny Appropriate Patient Access to Beta-Amyloid Imaging Agents, Including Amyvid™ (Florbetapir F 18 Injection), Despite Support From Experts, Patients and the Alzheimer's Disease Community
Yahoo/PR NewsWire
Sat, 09/28/13 - 11:11 am
Tags:
Medicare, Eli Lilly, Amyvid
3 Companies at the Cutting Edge of Diabetes Research
Motley Fool
Fri, 09/27/13 - 08:18 am
Tags:
diabetes, Eli Lilly, Merck, MannKind
Lilly drug fails in breast cancer, succeeds in gastric cancer
Reuters
Thu, 09/26/13 - 08:14 am
Tags:
Eli Lilly, gastric cancer, breast cancer, ramucirumab
Does Merck's R&D Program Need a Wake-Up Call?
Motley Fool
Thu, 09/26/13 - 08:09 am
Tags:
R&D, Merck, drug approvals, sugammadex, Pfizer, Eli Lilly, Sanofi, AstraZeneca
Lilly Bets Quality Will Pay Off in U.S. Diabetes Battle
Bloomberg
Wed, 09/25/13 - 08:41 am
Tags:
Eli Lilly, diabetes, Novo Nordisk, Bristol-Myers Squibb, Merck
Eli Lilly presents data from post-hoc analyses of linagliptin
Yahoo/Fly on the Wall
Tue, 09/24/13 - 10:09 am
Tags:
Eli Lilly, linagliptin, Boehringer Ingelheim, diabetes

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.